- Report
- May 2024
- 339 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 88 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- August 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 120 Pages
North America
From €3803EUR$4,000USD£3,195GBP
- Report
- February 2023
- 101 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- March 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2024
- 300 Pages
Global
From €2524EUR$2,655USD£2,120GBP
The In Vitro Diagnostics (IVD) Microbiology Technology market is a segment of the IVD industry that focuses on the development and commercialization of products and services used to detect, diagnose, and monitor infectious diseases. This includes products such as molecular diagnostics, culture media, and automated systems. These products are used to detect and identify microorganisms, including bacteria, viruses, fungi, and parasites. Additionally, they are used to monitor the effectiveness of treatments and to detect antibiotic resistance.
The IVD Microbiology Technology market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the need for improved patient outcomes. Additionally, the development of new technologies, such as next-generation sequencing, is expected to further drive the market.
Some companies in the IVD Microbiology Technology market include Becton Dickinson, Bio-Rad Laboratories, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more